Industry litigation – Page 16
-
BusinessTrade agreement could limit access to medicines
If approved in its leaked form, the Trans-Pacific Partnership would pose barriers for generic drugs to enter the market and keep drug prices high, warns the Foundation for Aids Research
-
Business
Injunction blocks first US biosimilar
Despite regulatory approval, Amgen is delaying sales of Sandoz’s version of filgrastim
-
Business
FDA accused of violating drug company’s freedom of speech
Amarin says the regulator is stopping it from giving ‘truthful, not misleading’ information to doctors about its fatty acid drug
-
Business
Takeda offers $2.4bn to settle diabetes litigation
Aims to settle multiple outstanding lawsuits relating to Actos (pioglitazone) and bladder cancer
-
BusinessKolon and Dupont settle trade secrets case
Korean firm admits stealing Kevlar technology and will pay $360m in fines and restitution
-
Business
Leak causes explosion at para-xylene plant in China
Twelve injured by explosion and fire caused by a leaking xylene tank at chemical plant
-
Business
Novartis accused of ‘derailing’ trials for cheap eye disease drug
BMJ says pharma giant is trying to block access to a drug that would save the NHS millions
-
Business
Drug firms warned to be honest with investors
Official warns of ‘significant consequences’ if companies aren’t forthcoming about their FDA interactions
-
BusinessUS opens up home DNA screening
FDA approves single disease genetic test and clears pathway for similar devices
-
BusinessHepatitis C drug patent challenged in Europe
Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent
-
Business
Fatal blast at Indian chemical plant
One worker killed and four injured at Survival Technologies plant in Ankleshwar
-
Business
EU regulator calls for generic drug suspensions
The EMA wants hundreds of formulations off the market after identifying systematic fraud in a major Indian contract clinical research organisation
-
Business
MFG Chemical fined after worker dies
Company cited for multiple safety failings before the fatal incident
-
Business
Ansun settles fraud case for $2m
Executives fiddled timesheets to overcharge US funding agency on grants and research contracts
-
-
BusinessUS poised to approve its first ‘biosimilar’ drug
FDA panel recommends Sandoz’s copy of Amgen’s Neupogen
-
-
Business
EU recommends Parkinson’s drug for approval
First new molecule for a decade, but Alzheimer’s still posing challenges as antibody treatment withdrawn from trials
-
Business
EU chemicals regulator scolded over animal testing
Ombudsman says ECHA isn’t doing enough to require alternative, non-animal methods
-
Business
Consumer products firms fined for French price fixing
€950m fines for ‘friends clubs’ that pushed up prices for home and personal care products